Table.2 Sample characteristics in mean (standard deviation) or frequency (percent) according to general obesity phenotypes in 6298 men in the SAMINOR 1 Survey (2003–2004)
Metabolically healthy non-obesity (N = 2972, 47.2%) | Metabolically unhealthy non-obesity (N = 1843, 29.2%) | Metabolically healthy obesity (N = 363, 5.8%) | Metabolically unhealthy obesity (N = 1120, 17.8%) | Total (N = 6298) | p-value | |
|---|---|---|---|---|---|---|
Age (years) | 51.4 (9.9) | 57.8 (10.8) | 51.3 (10.1) | 55.4 (10.3) | 54.0 (10.6) | < 0.0011 |
Ethnicity | 0.0022 | |||||
non-Sami | 2264 (76.2%) | 1452 (78.8%) | 253 (69.7%) | 865 (77.2%) | 4834 (76.8%) | |
Sami | 708 (23.8%) | 391 (21.2%) | 110 (30.3%) | 255 (22.8%) | 1464 (23.2%) | |
Smoking | < 0.0012 | |||||
Yes, currently | 1060 (35.7%) | 549 (29.8%) | 86 (23.7%) | 260 (23.2%) | 1955 (31.0%) | |
Yes, previously | 982 (33.0%) | 830 (45.0%) | 158 (43.5%) | 571 (51.0%) | 2541 (40.3%) | |
Never | 930 (31.3%) | 464 (25.2%) | 119 (32.8%) | 289 (25.8%) | 1802 (28.6%) | |
Died during follow-up | 297 (10.0%) | 402 (21.8%) | 39 (10.7%) | 200 (17.9%) | 938 (14.9%) | < 0.0012 |
Cause of death | < 0.0012 | |||||
Malignant tumor | 124 (41.8%) | 123 (30.6%) | 12 (30.8%) | 63 (31.5%) | 322 (34.3%) | |
CVD | 56 (18.9%) | 135 (33.6%) | 18 (46.2%) | 75 (37.5%) | 284 (30.3%) | |
Respiratory | 38 (12.8%) | 47 (11.7%) | 5 (12.8%) | 14 (7.0%) | 104 (11.1%) | |
Other | 75 (25.3%) | 91 (22.6%) | 3 (7.7%) | 41 (20.5%) | 210 (22.4%) | |
Unknown | 4 (1.3%) | 6 (1.5%) | 1 (2.6%) | 7 (3.5%) | 18 (1.9%) | |
Alcohol consumption | < 0.0012 | |||||
Weekly | 1046 (35.2%) | 545 (29.6%) | 117 (32.2%) | 315 (28.1%) | 2023 (32.1%) | |
Less than weekly | 1691 (56.9%) | 1057 (57.4%) | 213 (58.7%) | 683 (61.0%) | 3644 (57.9%) | |
Never/not last year | 235 (7.9%) | 241 (13.1%) | 33 (9.1%) | 122 (10.9%) | 631 (10.0%) | |
Leisure-time physical activity | < 0.0012 | |||||
Sedentary | 602 (20.3%) | 417 (22.6%) | 93 (25.6%) | 339 (30.3%) | 1451 (23.0%) | |
Light | 1571 (52.9%) | 1088 (59.0%) | 200 (55.1%) | 616 (55.0%) | 3475 (55.2%) | |
Moderate-hard | 799 (26.9%) | 338 (18.3%) | 70 (19.3%) | 165 (14.7%) | 1372 (21.8%) | |
Education (years) | 11.7 (3.8) | 10.6 (3.7) | 11.2 (3.4) | 10.8 (3.7) | 11.2 (3.8) | < 0.0011 |
General obesity | 0 (0.0%) | 0 (0.0%) | 363 (100.0%) | 1120 (100.0%) | 1483 (23.5%) | |
Metabolic syndrome | 0 (0.0%) | 970 (52.6%) | 0 (0.0%) | 900 (80.4%) | 1870 (29.7%) | < 0.0012 |
Hypertension | 1271 (42.8%) | 1493 (81.0%) | 164 (45.2%) | 972 (86.8%) | 3900 (61.9%) | < 0.0012 |
Increased waist circumference | 636 (21.4%) | 1031 (55.9%) | 331 (91.2%) | 1097 (97.9%) | 3095 (49.1%) | < 0.0012 |
Low HDL cholesterol | 258 (8.7%) | 592 (32.1%) | 22 (6.1%) | 488 (43.6%) | 1360 (21.6%) | < 0.0012 |
Elevated triglycerides | 825 (27.8%) | 1040 (56.4%) | 93 (25.6%) | 815 (72.8%) | 2773 (44.0%) | < 0.0012 |
Hyperglycemia | 44 (1.5%) | 230 (12.5%) | 3 (0.8%) | 163 (14.6%) | 440 (7.0%) | < 0.0012 |
Stroke | 0 (0.0%) | 100 (5.9%) | 0 (0.0%) | 51 (4.8%) | 151 (2.5%) | < 0.0012 |
Missing data | 6 | 145 | 0 | 52 | 203 | |
Angina pectoris | 0 (0.0%) | 318 (18.6%) | 0 (0.0%) | 138 (12.9%) | 456 (7.5%) | < 0.0012 |
Missing data | 6 | 137 | 0 | 48 | 191 | |
Myocardial infarction | 0 (0.0%) | 236 (13.7%) | 0 (0.0%) | 110 (10.2%) | 346 (5.7%) | < 0.0012 |
Missing data | 6 | 124 | 0 | 45 | 175 | |
Diabetes | 0 (0.0%) | 135 (7.9%) | 0 (0.0%) | 85 (7.9%) | 220 (3.6%) | < 0.0012 |
Missing data | 6 | 134 | 0 | 45 | 185 | |
Blood pressure-lowering drug | 0 (0.0%) | 837 (46.4%) | 0 (0.0%) | 504 (45.4%) | 1341 (21.5%) | < 0.0012 |
Missing data | 6 | 38 | 0 | 10 | 54 | |
Cholesterol-lowering drug | 0 (0.0%) | 630 (35.6%) | 0 (0.0%) | 320 (29.5%) | 950 (15.4%) | < 0.0012 |
Missing data | 6 | 74 | 0 | 35 | 115 | |
Glucose-lowering drug | 0 (0.0%) | 131 (7.7%) | 0 (0.0%) | 66 (6.3%) | 197 (3.2%) | < 0.0012 |
Missing data | 6 | 141 | 0 | 68 | 215 |